Vanda Pharmaceuticals
VNDA
#7758
Rank
A$0.39 B
Marketcap
$6.79
Share price
-0.92%
Change (1 day)
-9.21%
Change (1 year)

Earnings for Vanda Pharmaceuticals (VNDA)

Earnings in 2024 (TTM): -A$61.76 Million

According to Vanda Pharmaceuticals's latest financial reports the company's current earnings are A$0.19 Billion. a decrease over its 2023 earnings that were of -A$21.89 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Vanda Pharmaceuticals from 2005 to 2024

Annual earnings

Year Earnings Change
2024 -A$63.78 Million191.43%
2023 -A$21.89 Million-320.45%
2022 A$9.92 M-84.99%
2021 A$66.14 M54.8%
2020 A$42.72 M19.42%
2019 A$35.77 M4.93%
2018 A$34.09 M-228.6%
2017 -A$26.52 Million-8.98%
2016 -A$29.14 Million-53.79%
2015 -A$63.04 Million-30.18%
2014 -A$90.29 Million173.08%
2013 -A$33.06 Million-25.33%
2012 -A$44.28 Million163.61%
2011 -A$16.8 Million-221.15%
2010 A$13.86 M-124.53%
2009 -A$56.53 Million-29.44%
2008 -A$80.1 Million-36.2%
2007 -A$0.13 Billion21.81%
2006 -A$0.11 Billion170.55%
2005 -A$38.1 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
A$21.39 B-33,646.48%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
A$19.89 B-31,286.42%๐Ÿ‡บ๐Ÿ‡ธ USA
A$27.35 B-42,997.20%๐Ÿ‡บ๐Ÿ‡ธ USA
-A$13.15 Billion 20,507.48%๐Ÿ‡บ๐Ÿ‡ธ USA
A$17.43 B-27,431.53%๐Ÿ‡บ๐Ÿ‡ธ USA
-A$7.39 Million-88.43%๐Ÿ‡บ๐Ÿ‡ธ USA
A$33.26 B-52,256.91%๐Ÿ‡บ๐Ÿ‡ธ USA